Neoadjuvant chemoradiotherapy esophageal adenocarcinoma. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Esophagus Cardia Esophagogastric Junction Cell Line, Tumor Mucous Membrane Tumor Cells, Cultured Lymph Nodes Chromosomes, Human, Pair 17 Larynx Duodenum Epithelium Chromosomes, Human, Pair 9

Organisms1

Diseases67

Adenocarcinoma Esophageal Neoplasms Barrett Esophagus Rectal Neoplasms Carcinoma, Squamous Cell Neoplasm Recurrence, Local Stomach Neoplasms Precancerous Conditions Gastroesophageal Reflux Metaplasia Lung Neoplasms Duodenogastric Reflux Pancreatic Neoplasms Head and Neck Neoplasms Disease Progression Lymphatic Metastasis Esophagitis, Peptic Breast Neoplasms Esophagitis Nasopharyngeal Neoplasms Adenocarcinoma, Mucinous Neoplasm Invasiveness Carcinoma, Non-Small-Cell Lung Carcinoma, Pancreatic Ductal Uterine Cervical Neoplasms Adenocarcinoma, Papillary Hypopharyngeal Neoplasms Muscle Neoplasms Adenocarcinoma, Bronchiolo-Alveolar Carcinoma Radiation Injuries Neoplasm, Residual Laryngeal Neoplasms Neoplasm Metastasis Deglutition Disorders Oropharyngeal Neoplasms Mucositis Aneuploidy Anus Neoplasms Urinary Bladder Neoplasms Prostatic Neoplasms Carcinoma, Signet Ring Cell Cell Transformation, Neoplastic Colonic Neoplasms Carcinoma, Small Cell Carcinoma, Ductal, Breast Otorhinolaryngologic Neoplasms Sarcoma Pelvic Neoplasms Carcinoma, Adenosquamous Leukopenia Carcinoma, Transitional Cell Osteosarcoma Bone Neoplasms Colorectal Neoplasms Carcinoma, Lobular Neoplasms, Squamous Cell Radiation Pneumonitis Nose Neoplasms Liver Neoplasms Stomatitis Voice Disorders Endometrial Neoplasms Genetic Predisposition to Disease Carcinoma, Large Cell Postoperative Complications Neoplasms, Multiple Primary

Chemicals and Drugs61

Fluorouracil Cisplatin Tumor Markers, Biological Antineoplastic Agents Deoxycytidine Taxoids Antimetabolites, Antineoplastic Paclitaxel Carboplatin Epirubicin Doxorubicin Fetuin-B Fluorodeoxyglucose F18 Organoplatinum Compounds Leucovorin Receptor, erbB-2 Cyclophosphamide DNA, Neoplasm Radiopharmaceuticals Cyclooxygenase 2 Vinblastine Radiation-Sensitizing Agents Anthracyclines Antibodies, Monoclonal, Humanized Tegafur Oxonic Acid Ki-67 Antigen Tumor Suppressor Protein p53 Deoxycholic Acid Hydroxyurea Mitomycin RNA, Messenger Ifosfamide Biomarkers, Pharmacological Receptors, Estrogen Neoplasm Proteins Xeroderma Pigmentosum Group D Protein Etoposide Receptors, Progesterone Camptothecin Antibodies, Monoclonal Methotrexate Cyclooxygenase 1 Antineoplastic Agents, Hormonal Antineoplastic Agents, Phytogenic RNA, Neoplasm Antineoplastic Agents, Alkylating Bile Acids and Salts Receptor, Epidermal Growth Factor Anti-Inflammatory Agents, Non-Steroidal Bridged Compounds Keratin-7 Membrane Proteins Cyclooxygenase Inhibitors Nitriles Prostaglandin-Endoperoxide Synthases Androgen Antagonists Cyclin D1 Vincristine MicroRNAs RNA, Small Interfering

Analytical, Diagnostic and Therapeutic Techniques and Equipment91

Neoadjuvant Therapy Chemoradiotherapy, Adjuvant Chemoradiotherapy Esophagectomy Radiotherapy, Adjuvant Chemotherapy, Adjuvant Combined Modality Therapy Neoplasm Staging Treatment Outcome Prognosis Disease-Free Survival Survival Rate Kaplan-Meier Estimate Survival Analysis Antineoplastic Combined Chemotherapy Protocols Retrospective Studies Esophagoscopy Radiotherapy Dosage Immunohistochemistry Radiotherapy Follow-Up Studies Dose Fractionation Risk Factors Positron-Emission Tomography Induction Chemotherapy Preoperative Care Drug Administration Schedule Prospective Studies Case-Control Studies Biopsy Predictive Value of Tests Radiotherapy, Conformal Digestive System Surgical Procedures Gastrectomy Tissue Array Analysis Proportional Hazards Models Cystectomy Organ Sparing Treatments Multivariate Analysis Incidence Lymph Node Excision Remission Induction Neoplasm Grading Tomography, X-Ray Computed Brachytherapy Reverse Transcriptase Polymerase Chain Reaction Risk Assessment Gene Expression Profiling Immunoenzyme Techniques Biopsy, Needle Endoscopy, Digestive System Radiotherapy, Intensity-Modulated Feasibility Studies Oligonucleotide Array Sequence Analysis Odds Ratio Multimodal Imaging Tumor Burden Clinical Trials, Phase II as Topic Pneumonectomy Cohort Studies Sensitivity and Specificity Randomized Controlled Trials as Topic Radiotherapy, High-Energy Postoperative Care Clinical Trials as Topic Polymerase Chain Reaction Laryngectomy Anastomosis, Surgical Treatment Failure Salvage Therapy Logistic Models Confidence Intervals Endoscopy Pancreaticoduodenectomy Pancreatectomy SEER Program In Situ Hybridization, Fluorescence Endosonography Real-Time Polymerase Chain Reaction Magnetic Resonance Imaging Patient Selection Radiation Dosage Blotting, Western Cluster Analysis Diagnostic Errors Infusions, Intravenous Lymphatic Irradiation Fatal Outcome Maximum Tolerated Dose Photochemotherapy Mastectomy

Psychiatry and Psychology1

Phenomena and Processes23

Gene Expression Regulation, Neoplastic Time Factors Loss of Heterozygosity Gene Amplification Odds Ratio Aneuploidy Cell Proliferation Sensitivity and Specificity Apoptosis DNA Methylation Genes, erbB-2 Genes, p16 Polymorphism, Single Nucleotide Chromosomes, Human, Pair 17 Gene Dosage Radiation Dosage Genotype Drug Resistance, Neoplasm Maximum Tolerated Dose Genetic Predisposition to Disease Up-Regulation Chromosomes, Human, Pair 9 Signal Transduction

Disciplines and Occupations1

Immunohistochemistry

Technology, Industry, Agriculture1

Carbonated Beverages

Information Science6

Survival Rate Radiotherapy, Conformal Incidence Radiotherapy, Intensity-Modulated SEER Program Fatal Outcome

Health Care34

Treatment Outcome Disease-Free Survival Survival Rate Kaplan-Meier Estimate Survival Analysis Retrospective Studies Follow-Up Studies Risk Factors Preoperative Care Prospective Studies Case-Control Studies Predictive Value of Tests Proportional Hazards Models Multivariate Analysis Incidence Radiation Injuries Risk Assessment Feasibility Studies Odds Ratio Clinical Trials, Phase II as Topic Cohort Studies Sensitivity and Specificity Randomized Controlled Trials as Topic Postoperative Care Clinical Trials as Topic Treatment Failure Logistic Models Confidence Intervals SEER Program Patient Selection Radiation Dosage Cluster Analysis Diagnostic Errors Fatal Outcome

Geographicals2

United States Sweden

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Neoadjuvant Therapy Chemoradiotherapy, Adjuvant Adenocarcinoma Esophageal Neoplasms Chemoradiotherapy Barrett Esophagus Esophagectomy Rectal Neoplasms Radiotherapy, Adjuvant Chemotherapy, Adjuvant Combined Modality Therapy Neoplasm Staging Carcinoma, Squamous Cell Fluorouracil Treatment Outcome Prognosis Disease-Free Survival Survival Rate Kaplan-Meier Estimate Survival Analysis Antineoplastic Combined Chemotherapy Protocols Retrospective Studies Neoplasm Recurrence, Local Cisplatin Esophagus Cardia Stomach Neoplasms Esophagogastric Junction Precancerous Conditions Esophagoscopy Gastroesophageal Reflux Metaplasia Radiotherapy Dosage Lung Neoplasms Tumor Markers, Biological Antineoplastic Agents Duodenogastric Reflux Pancreatic Neoplasms Head and Neck Neoplasms Immunohistochemistry Deoxycytidine Taxoids Disease Progression Radiotherapy Lymphatic Metastasis Follow-Up Studies Gene Expression Regulation, Neoplastic Esophagitis, Peptic Breast Neoplasms Esophagitis Antimetabolites, Antineoplastic Dose Fractionation Nasopharyngeal Neoplasms Paclitaxel Risk Factors Adenocarcinoma, Mucinous Positron-Emission Tomography Cell Line, Tumor Induction Chemotherapy Carboplatin Preoperative Care Neoplasm Invasiveness Carcinoma, Non-Small-Cell Lung Drug Administration Schedule Prospective Studies Epirubicin Case-Control Studies Doxorubicin Fetuin-B Carcinoma, Pancreatic Ductal Time Factors Fluorodeoxyglucose F18 Biopsy Organoplatinum Compounds Predictive Value of Tests Uterine Cervical Neoplasms Radiotherapy, Conformal Digestive System Surgical Procedures Leucovorin Adenocarcinoma, Papillary Gastrectomy Tissue Array Analysis Receptor, erbB-2 Hypopharyngeal Neoplasms Proportional Hazards Models Cystectomy Organ Sparing Treatments Multivariate Analysis Incidence Lymph Node Excision Muscle Neoplasms Remission Induction Adenocarcinoma, Bronchiolo-Alveolar Carcinoma Cyclophosphamide Loss of Heterozygosity Neoplasm Grading Tomography, X-Ray Computed Brachytherapy DNA, Neoplasm

No FAQ available that match "neoadjuvant chemoradiotherapy esophageal adenocarcinoma"